Comparative Efficacy of 35 % Glycolic Acid Peel versus 4 % Retinol Peel in Melasma

Taku Rini1, Rashmi Sarkar, Bharati Verma

  • 1All authors are affiliated with the Department of Dermatology, Lady Hardinge Medical College, New Delhi, India.

Abstract

Insights

Both glycolic acid and retinol peels effectively treat melasma, improving skin pigmentation and quality of life. Dermoscopy aids in assessing treatment response for this common skin condition.

Area of Science:

  • Dermatology
  • Cosmetic Science

Background:

  • Melasma is an acquired hyperpigmentation condition.
  • Chemical peels are recognized treatments for melasma.
  • Comparative studies on different chemical peels for melasma, especially using dermoscopy, are limited.

Purpose of the Study:

  • To compare the efficacy of 35% glycolic acid peel versus 4% retinol peel for melasma treatment.
  • To evaluate treatment outcomes using clinical, dermoscopic, and quality of life assessments.
  • To determine the utility of dermoscopy in assessing melasma treatment response.

Main Methods:

  • A randomized controlled trial involving 60 adult melasma patients.
  • Participants were assigned to either glycolic acid or retinol peel groups.
  • Six bi-weekly peel sessions were administered, with assessments including modified Melasma Area Severity Index (mMASI), dermoscopic scoring, and Hindi Melasma Quality of Life Index (HI-MELASQOL).

Main Results:

  • Both glycolic acid and retinol peels significantly improved mMASI scores, dermoscopic features, and quality of life (HI-MELASQOL).
  • No statistically significant difference in efficacy was found between the two peel types.
  • Mild, transient adverse effects were more frequent in the retinol group (13.3%) compared to the glycolic acid group (3.3%).

Conclusions:

  • Both 35% glycolic acid and 4% retinol peels are effective treatments for melasma.
  • Significant improvements in pigmentation, dermoscopic findings, and patient-reported quality of life were observed with both treatments.
  • Dermoscopy is a valuable tool for monitoring treatment response in melasma.